February 27, 2023
The Japanese health ministry on February 24 approved label expansions for a batch of medicines including a pediatric indication for Pfizer’s sedative agent Precedex (dexmedetomidine). An α2 agonist, Precedex is now approved for sedation during non-invasive procedures and tests in...read more